FMT Shows Promise for Peanut Allergy Tolerance in Phase I Trial

A small Phase I trial found that fecal microbiome transplantation (FMT) increased peanut tolerance in some adults with a peanut allergy, while mouse studies suggested the effect may depend on bile acid metabolites.

The post FMT Shows Promise for Peanut Allergy Tolerance in Phase I Trial appeared first on GEN - Genetic Engineering and Biotechnology News.